2025-11-14T10:46:35-06:00 2024-12-31 721473527 HIENZ & MACALUSO LLC 110 VETERANS BLVD SUITE 170 METAIRIE LA 70005 990 2024-01-01 471643994 ANSWER ALS ANSW 8004902375 2021 LAKESHORE DRIVE SUITE 304 NEW ORLEANS LA 70122 CLARE DURRETT MANAGING COORDINATOR 8004902375 2025-11-10 1 1 REBECCA K BOUCHON P00964863 5048375434 2025-11-10 2024 2025-03-06 01:10:19Z CLARE DURRETT 2021 LAKESHORE DRIVE SUITE 304 NEW ORLEANS LA 70122 2817907 0 X WWW.ANSWERALS.ORG X 2014 LA TO FIND SOLUTIONS FOR PEOPLE LIVING WITH ALS NOW AND FOR THE FUTURE BY UTILIZING KNOWLEDGE OF PATIENTS, LEADING RESEARCHERS AND TECHNOLOGY TO SEEK IMMEDIATE SOLUTIONS TO IMPROVE THE LIVES OF THOSE LIVING WITH ALS UNTIL A TREATMENT OR CURE IS FOUND; DISCOVER WHAT CAUSES ALS; DEVELOP MODELS TO UNDERSTAND ALS AND SCREEN FOR DRUG AND CELLULAR THERAPY; DISCOVER THERAPIES THAT COULD SUBSTANTIALLY SLOW OR HALT THE PROGRESS OF ALS AND ULTIMATELY CURE THE DISEASE; PROVIDE ALL GATHERED INFORMATION FREE FOR WORLDWIDE USE BY CLINICIANS, SCIENTISTS AND PHARMA TO RAPIDLY ADVANCE THERAPEUTICS. 9 9 1 20 0 0 3485831 2666669 0 0 132036 151238 33449 0 3651316 2817907 2036876 2621161 0 0 65832 66803 0 0 38384 787743 557920 2890451 3245884 760865 -427977 7363198 7362169 37716 464664 7325482 6897505 X TO FIND SOLUTIONS FOR PEOPLE LIVING WITH ALS NOW AND FOR THE FUTURE BY UTILIZING KNOWLEDGE OF PATIENTS, LEADING RESEARCHERS AND TECHNOLOGY TO SEEK IMMEDIATE SOLUTIONS TO IMPROVE THE LIVES OF THOSE LIVING WITH ALS UNTIL A TREATMENT OR CURE IS FOUND; DISCOVER WHAT CAUSES ALS; DEVELOP MODELS TO UNDERSTAND ALS AND SCREEN FOR DRUG AND CELLULAR THERAPY; DISCOVER THERAPIES THAT COULD SUBSTANTIALLY SLOW OR HALT THE PROGRESS OF ALS AND ULTIMATELY CURE THE DISEASE; PROVIDE ALL GATHERED INFORMATION FREE FOR WORLDWIDE USE BY CLINICIANS, SCIENTISTS AND PHARMA TO RAPIDLY ADVANCE THERAPEUTICS. 0 0 3140619 2621161 CREATING THE LARGEST AND MOST COMPREHENSIVE FOUNDATION OF ALS DATA EVER AMASSED, ENCOMPANSING CLINICAL, CHEMICAL, GENETIC, PROTEIN, HISTORICAL AND BIOLOGICAL DATA FROM AN ENORMOUS SAMPLING OF ALS PATIENTS IN THE UNITED STATES. IN COLLABORATION WITH MACHINE LEARNING AND BIG DATA TECHNOLOGY, THE DATA WILL BE MINED TO UNCOVER ALS CAUSES, SUBTYPES, PATHWAYS GONE AWRY AND DRUG TARGETS. THIS WILL ESTABLISH A LARGE AND CRITICAL FOUNDATION FOR NEW CLINICAL TRIALS, DEVELOP NEW WAYS TO CATEGORIZE PATIENTS TO IDENTIFY SPECIFIC DRUGGABLE PATHWAYS AND SUBTYPE BIOMARKERS AND DISEASE PATHOPHYSIOLOGY TO AID NOT ONLY IN EARLY DIAGNOSIS OF THE DISEASE, BUT ALSO TO MONITOR THE EFFICACY OF NEWLY DEVELOPED TREATMENTS. 3140619 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 2 0 1 1 1 0 0 0 0 0 0 0 0 0 0 X 9 9 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X LIZ HATCH ACCOUNTING 5043096393 190 E OAKRIDGE PARK METAIRIE LA 70005 X BEVERLY GOULET BOARD CHAIR 1.00 X X 0 0 0 CLARE DURRETT MANAGING DIRECTOR 20.00 X X 0 0 0 PAUL VARISCO BOARD MEMBER 5.00 X X 0 0 0 STEVE GLEASON BOARD MEMBER 1.00 X 0 0 0 WILLIAM J QUINLAN JR BOARD MEMBER 1.00 X 0 0 0 STEVE FINKBEINER BOARD MEMBER 1.00 X 0 0 0 PAT QUINN BOARD MEMBER EMERITUS 1.00 X 0 0 0 S MICHELLE FARR BOARD MEMBER 1.00 X 0 0 0 ELIZABETH BRUCE BOARD MEMBER 1.00 X 0 0 0 JOHN COSTELLO BOARD MEMBER 1.00 X 0 0 0 COLLEEN STEPHENS CHIEF OF STAFF 40.00 X 0 0 0 0 0 0 0 0 0 0 0 2666669 2666669 151238 151238 2817907 151238 0 0 2621161 2621161 62000 62000 4803 4803 21965 21965 57478 32737 8329 16412 6832 5986 66 780 7085 425 6613 47 58791 54026 4018 747 110136 106168 12 3956 1708 1196 512 9085 9085 PROGRAM DEVELOPMENT 242430 241382 1048 OTHER FUNDRAISING EXPEN 13289 13289 LEASE EXPENSE 12298 12298 WEBSITE MAINTENANCE 7192 7192 9631 3543 3447 2641 3245884 3140619 66881 38384 6451283 6485165 868235 780952 21971 6971 5732 62522 559694 556420 4982 3274 10995 23285 7363198 7362169 27361 57375 385000 10355 22289 37716 464664 X 4841412 5916553 2484070 980952 7325482 6897505 7363198 7362169 -427977 0 X 0 1 X 0 0 X 2276502 1800662 1985330 3485831 2666669 12214994 2276502 1800662 1985330 3485831 2666669 12214994 4482992 7732002 12214994 0.63300 0.63310 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 559694 556420 3274 3274 LEASE LIABILITY 22289 22289 X 2943289 125382 125382 2817907 0 2817907 3371266 125382 125382 3245884 0 3245884 PART X, LINE 2: ACCOUNTING STANDARDS PROVIDE DETAILED GUIDANCE FOR FINANCIAL STATEMENT RECOGNITION, MEASUREMENT AND DISCLOSURE OF UNCERTAIN TAX POSITIONS RECOGNIZED IN AN ENTITY'S FINANCIAL STATEMENTS.AS OF DECEMBER 31, 2018, MANAGEMENT OF THE ORGANIZATION BELIEVES THAT IT HAS NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. 0 JOHN HOPKINS UNIVERSITY SCHOOL OF MEDICINE 855 NORTH WOLFE STREET RM 270 BALTIMORE MD 21205 1029803 0 GRANT TO FUND ALS RESEARCH. ALMAGU 477 MADISON AVE FLOOR 6 NEW YORK NY 10022 14900 0 GRANT TO FUND ALS RESEARCH. CEDARS SINAI HOSPITAL 8700 BEVERLY BLVD LOS ANGELES CA 90048 523889 0 GRANT TO FUND ALS RESEARCH. DIAGENODE LLC 400 MORRIS AVE SUITE 101 DENVILLE NJ 07834 229531 0 GRANT TO FUND ALS RESEARCH. LOUISIANA STATE UNIVERSITY 5429 AIRLINE HIGHWAY BATON ROUGE LA 70805 41973 0 GRANT TO FUND ALS RESEARCH. ON POINT SCIENTIFIC 442 ROUTE 206 MONTAGUE NJ 07827 487346 0 GRANT TO FUND ALS RESEARCH. ANTARES FORMERLY CONTINGASOFT 2045 LAKESHORE DRIVE SUITE 349 NEW ORLEANS LA 70122 60678 0 GRANT TO FUND ALS RESEARCH. FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH 1100 ROCKVILLE PIKE SUITE 600 BETHESDA MD 20852 10000 0 GRANT TO FUND ALS RESEARCH. PENNINGTON BIOMEDICAL RESEARCH CENTER 6400 PERKINS ROAD BATON ROUGE LA 70808 41947 0 GRANT TO FUND ALS RESEARCH. UNIVERSITY OF NEW ORLEANS OFFICE OF RESEARCH 1005 ADMINISTRATION ANNEX BUILDING 2000 LAKESHORE DRIVE NEW ORLEANS LA 70148 6995 0 GRANT TO FUND ALS RESEARCH. MICROSOFT ONE MICROSOFT WAY REDMOND WA 98052 174099 0 GRANT TO FUND ALS RESEARCH. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE ORGANIZATION'S FORM 990 WILL BE PROVIDED TO THE ORGANIZATION'S GOVERNING BODY FOR REVIEW PRIOR TO IT BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD REVIEWS AND ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION C, LINE 18 FORM 1023 IS AVAILABLE UPON REQUEST. FORM 990, PART VI, SECTION C, LINE 19 NO DOCUMENTS ARE PROVIDED TO THE GENERAL PUBLIC. GLEASON INITIATIVE FOUNDATION PO BOX 24493 NEW ORLEANS LA 70124 453689316 SEE PART VII EXPLANATION LA 501(C)(3) LINE 7 N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 GLEASON INITIATIVE FOUNDATION C FMV